Skip to content

Insider · CIK 0001245377

Jeffrey J Brown

director

Files at MED (MEDIFAST INC), UPBD (UPBOUND GROUP, INC.). First filing Oct 26, 2023, latest Jul 9, 2026.

In brief

Jeffrey J Brown files SEC Form 4 as director at UPBD (UPBOUND GROUP, INC.), and also at MED (MEDIFAST INC). Since Oct 26, 2023, Jeffrey J Brown has reported 11 open-market buys worth $874k and 0 open-market sells worth $0, the latest filed on Jul 9, 2026.

After Jeffrey J Brown's past buys, the stock trailed the S&P 500 by a median 16.3% over six months (n = 7), and 14% of those buys were ahead of the index at six months. InsiderTell labels that a negative record.

The newest scored trade: bought $46k of UPBD on Jul 7, 2026, filed Jul 9, 2026, scored 33 (weak). In the last 12 months: 4 buys worth $179k and 0 sells worth $0.

Track record
Negative
Past buys trailed the index over six months, median.
Median 6-month excess
-16.3%
after past buys, n = 7
Hit rate
14%
past buys that beat the index over 6 months
Open-market trades
11 / 0
$874k bought, $0 sold

Where the trades landed

Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.

UPBD: UPBOUND GROUP, INC.

UPBDOct 9, 2026 · close 15.40

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

MED: MEDIFAST INC

MEDOct 9, 2026 · close 11.61

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
33Weak
UPBDbuy
UPBOUND GROUP, INC.
$46k
2,295 shares
+10%+36% from low-19% from high
28Weak
UPBDbuy
UPBOUND GROUP, INC.
$45k
2,329 shares
+10%+24% from low-26% from high
37Weak
UPBDbuy
UPBOUND GROUP, INC.
$44k
2,502 shares
+11%+19% from low-34% from high
32Weak
UPBDbuy
UPBOUND GROUP, INC.
$43k
1,951 shares
+9%+19% from low-31% from high
33Weak
UPBDbuy
UPBOUND GROUP, INC.
$43k
1,653 shares
+8%+34% from low-22% from high
54Moderate
UPBDbuy
UPBOUND GROUP, INC.
$516k
21,730 shares
-+17% from low-31% from high
39Weak
UPBDbuy
UPBOUND GROUP, INC.
$34k
1,694 shares
+2%+3% from low-40% from high
26Weak
UPBDbuy
UPBOUND GROUP, INC.
$33k
1,146 shares
+1%-
20Weak
UPBDbuy
UPBOUND GROUP, INC.
$31k
1,065 shares
+1%-
36Weak
MEDbuy 2
MEDIFAST INC
$11k
155 shares
+4%+2% from low-43% from high
19Weak
UPBDbuy
UPBOUND GROUP, INC.
$27k
988 shares
+1%+50% from low-25% from high

Transactions

Every row this insider has filed, 36 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+6,220$15.70$98k178,90311 d ago
Jul 7, 2026UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: by the Jeffrey J Brown Living Trust
+454$20.09$9,12123,853Jul 9, 2026
Jul 7, 2026UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: by Brown Equity Partners, LLC
+1,841$20.09$37k96,681Jul 9, 2026
Jul 7, 2026UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+2,524$20.53$52k172,683Jul 9, 2026
Jul 1, 2026UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+4,602$21.22$98k170,159Jul 2, 2026
Apr 28, 2026UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: by the Jeffrey J Brown Living Trust
+461$19.41$8,94823,399Apr 30, 2026
Apr 28, 2026UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: by Brown Equity Partners, LLC
+1,868$19.41$36k94,840Apr 30, 2026
Apr 28, 2026UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+2,636$19.17$51k165,557Apr 30, 2026
Apr 1, 2026UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+5,410$18.05$98k162,921Apr 2, 2026
Jan 6, 2026UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: by the Jeffrey J Brown Living Trust
+495$17.68$8,75222,938Jan 8, 2026
Jan 6, 2026UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: by Brown Equity Partners, LLC
+2,007$17.68$35k92,972Jan 8, 2026
Jan 6, 2026UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+2,271$17.64$40k157,511Jan 8, 2026
Jan 2, 2026UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+13,818$17.56$243k155,240Jan 5, 2026
Oct 21, 2025UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: by the Jeffrey J Brown Living Trust
+386$22.27$8,59622,443Oct 23, 2025
Oct 21, 2025UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: by Brown Equity Partners, LLC
+1,565$22.27$35k90,965Oct 23, 2025
Oct 21, 2025UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+1,664$22.37$37k141,422Oct 23, 2025
Oct 1, 2025UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+4,133$23.63$98k139,758Oct 2, 2025
Jul 8, 2025UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: by the Jeffrey J Brown Living Trust
+327$25.90$8,46922,057Jul 9, 2025
Jul 8, 2025UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: by Brown Equity Partners, LLC
+1,326$25.90$34k89,400Jul 9, 2025
Jul 8, 2025UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+1,351$25.66$35k135,625Jul 9, 2025
Jul 1, 2025UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+3,891$25.10$98k134,274Jul 1, 2025
Jun 25, 2025MED
MEDIFAST INC
AGrant or award
Common Stock
+11,168$0.00$029,128Jun 26, 2025
Jun 25, 2025MED
MEDIFAST INC
AGrant or award
Common Stock
+9,449$13.39$127k38,578Jun 26, 2025
May 6, 2025UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: by the Jeffrey J Brown Living Trust
+21,730$23.75$516k21,730May 7, 2025
Apr 22, 2025UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: (1)
+1,694$19.89$34k88,074Apr 23, 2025
Apr 22, 2025UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+1,693$19.99$34k130,383Apr 23, 2025
Apr 1, 2025UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+4,076$23.96$98k128,690Apr 2, 2025
Jan 7, 2025UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: (1)
+1,146$29.01$33k86,380Jan 10, 2025
Jan 7, 2025UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+944$28.97$27k124,614Jan 10, 2025
Jan 2, 2025UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+8,318$29.17$243k123,670Jan 6, 2025
Oct 22, 2024UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: (1)
+1,065$29.25$31k85,234Oct 24, 2024
Oct 22, 2024UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+886$28.82$26k115,352Oct 24, 2024
Nov 3, 2023MED
MEDIFAST INC
POpen-market purchase
Common Stockindirect: Jeffrey Brown Living Trust
+97$70.55$6,8254,233Nov 9, 2023
Nov 7, 2023MED
MEDIFAST INC
POpen-market purchase
Common Stock
+58$68.89$4,0205,784Nov 9, 2023
Oct 24, 2023UPBD
UPBOUND GROUP, INC.
POpen-market purchase
COMMON STOCKindirect: (1)
+988$27.61$27k81,235Oct 26, 2023
Oct 24, 2023UPBD
UPBOUND GROUP, INC.
AGrant or award
Director Deferred Stock Unitderivative
+574$0.00$096,626Oct 26, 2023

Questions about Jeffrey J Brown

Answered from the filings on this page, as of the latest one.

Is Jeffrey J Brown buying or selling?

In the last 12 months Jeffrey J Brown reported 4 open-market buys worth $179k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $46k of UPBD on Jul 7, 2026. Grants, option exercises and tax withholding are not counted.

How did Jeffrey J Brown's past buys perform?

Measured from the first close after each filing, the stock trailed the S&P 500 by a median 16.3% over six months across 7 past buys, with 14% ahead of the index. Past results describe what happened; they do not predict the next trade.

Where does Jeffrey J Brown file Form 4?

Jeffrey J Brown has filed Form 4 at UPBD (UPBOUND GROUP, INC.); MED (MEDIFAST INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jeffrey J Brown: insider trades and track record | InsiderTell